BioSpace News Archive

Mylan achieves key milestone to provide U.S. diabetes patients with more affordable generic version of Sanofi’s Lantus® insulin glargine vials

Galderma Laboratories, L.P., a global leader focused on meeting the world’s increasing skin health needs, announced today an expansion to its roster of collaborations in the U.S. with professional-grade skincare brands, REVISION SKINCARE®, ALASTIN Skincare®, and SENTÉ®, to bring additional value to aesthetic providers and their patients

BaseHealth, a predictive health analytics company that empowers health systems and Medicare Advantage (MA) plans to proactively manage rising risk within populations, has introduced the first predictive analytics platform that mines clinical laboratory data, enabling healthcare organizations (HCOs) to improve population health, boost quality scores and optimize risk adjustment.

DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of innovative healthcare services and solutions to federal agencies, today announced financial results for its fiscal fourth quarter and the fiscal year ended September 30, 2018.

MabVax Therapeutics Holdings, Inc. today announced that it has engaged Objective Capital Partners, LLC, to serve as a financial advisor to assist the Company in exploring the sale of clinical and preclinical assets of the Company with the goal of maximizing the value of these assets within the near term.

The Phase 2b trial is being conducted in the United States, United Kingdom, Netherlands, Denmark and the Czech Republic.

Henry Schein, Inc. announced today that its Board of Directors has authorized the repurchase of up to $400 million of shares of the Company’s common stock.

Award intended to fund Phase 2 study of brivoligide in patients undergoing mastectomy

The American Urological Association (AUA) is pleased to announce recipients of its 2019 AUA Awards Program. Each year, the AUA recognizes physicians, researchers, educators and other individuals for their outstanding career contributions to the field of medicine, the specialty of urology and the AUA.

SiteZeus is pleased to announce a new partnership with The Vitamin Shoppe® (NYSE: VSI), a specialty retailer that provides nutritional products across a portfolio of more than 775 company-operated stores.